In Brief
This article was originally published in The Tan Sheet
Executive Summary
EC waives GMP documentation for U.S. APIs; MHRA restricts codeine use; organic selenium urged for infant formula; NBTY agrees to settle glucosamine class action; currant products dubbed drugs; FDA warns about more spiked supplements; retailer recalls DMAA products; more news In Brief.